Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | PCVX | BPMC | ||
| Company | Apellis Pharmaceuticals Inc | Vaxcyte Inc | Blueprint Medicines Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 48.18 | 61.79 | 90.48 | ||
| High | 50.00 | 62.56 | 94.67 | ||
| Low | 47.97 | 60.83 | 89.19 | ||
| Last | 48.72 | 60.88 | 92.29 | ||
| Change | +1.08 | -0.72 | +1.68 | ||
| % Change | +2.27% | -1.17% | +1.85% | ||
| Volume | 1,184,900 | 665,900 | 788,700 | ||
| 20-Day Average Volume | 1,203,510 | 667,115 | 615,915 | ||
| Previous Close | 47.64 | 61.60 | 90.61 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 53.83 | 63.83 | 90.69 | ||
| 20-Day Raw Stochastic | 17.17% | 14.47% | 62.83% | ||
| 20-Day Relative Strength | 36.14% | 39.30% | 54.10% | ||
| Weighted Alpha | -10.92 | +33.63 | +86.12 | ||
| Today's Opinion | 40% Sell | 8% Buy | 88% Buy | ||
| Previous Opinion | 40% Sell | 8% Buy | 88% Buy | ||
| Last Month's Opinion | 8% Buy | 56% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.98% since 04/16/24 | -2.19% since 04/16/24 | +7.20% since 04/16/24 | ||
| Low | 46.40 on 04/18/24 | 59.39 on 04/19/24 | 84.62 on 04/19/24 | ||
| High | 52.44 on 04/17/24 | 63.44 on 04/17/24 | 94.67 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -12.04% since 03/22/24 | -9.45% since 03/22/24 | +6.03% since 03/22/24 | ||
| Low | 46.40 on 04/18/24 | 59.39 on 04/19/24 | 84.33 on 04/15/24 | ||
| High | 59.91 on 04/01/24 | 69.68 on 03/28/24 | 97.00 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | -26.38% since 01/23/24 | -6.50% since 01/23/24 | +11.06% since 01/23/24 | ||
| Low | 46.40 on 04/18/24 | 59.39 on 04/19/24 | 72.24 on 02/14/24 | ||
| High | 71.90 on 02/26/24 | 82.04 on 02/28/24 | 101.00 on 02/28/24 | ||
| 6-Month | |||||
| %Chg | +7.31% since 10/23/23 | +29.81% since 10/23/23 | +109.04% since 10/23/23 | ||
| Low | 41.19 on 11/06/23 | 45.61 on 10/26/23 | 43.89 on 10/25/23 | ||
| High | 73.80 on 01/09/24 | 82.04 on 02/28/24 | 101.00 on 02/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,744,526 | 6,699,555 | 5,545,332 | ||
| Shares Outstanding, K | 120,582 | 108,759 | 61,200 | ||
| Annual Sales | 396,590,000 | 0 | 249,380,000 | ||
| Annual Net Income | -528,630,000 | -402,270,000 | -506,980,000 | ||
| Last Quarter Sales | 146,380,000 | 0 | 71,960,000 | ||
| Last Quarter Net Income | -88,580,000 | -180,800,000 | -110,920,000 | ||
| 60-Month Beta | 0.88 | 0.89 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 02/27/24 | -1.82 on 02/27/24 | -1.82 on 02/15/24 | ||
| Latest Earnings Date | 05/02/24 | 05/13/24 | 05/02/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||